66.88
Crispr Therapeutics Ag Aktie (CRSP) Neueste Nachrichten
Crispr Therapeutics: Shares Are SoaringThis Could Be The Start Of Something Big (CRSP) - Seeking Alpha
What drives CRISPR Therapeutics AG stock priceExceptional trading results - Autocar Professional
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - MSN
Private Advisor Group LLC Increases Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics AG Stock Analysis and ForecastHigh-yield growth strategies - Autocar Professional
Is CRISPR Therapeutics AG a good long term investmentAccelerated investment success - jammulinksnews.com
Research Analysts Set Expectations for CRSP Q2 Earnings - MarketBeat
Bank of America Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $78.00 - MarketBeat
Crispr Therapeutics price target lowered to $78 from $79 at BofA - TipRanks
What analysts say about CRISPR Therapeutics AG stockDynamic profit expansion - jammulinksnews.com
CRISPR Therapeutics' Stock Surge: A Glimpse into the Future of Gene-Editing Investment - AInvest
CRISPR Therapeutics (NASDAQ:CRSP) Sees Large Volume IncreaseStill a Buy? - MarketBeat
CRISPR Therapeutics Rises Amid Gene Editing Breakthroughs - StocksToTrade
CRISPR Stock (CRSP) Continues to Sizzle on Insider Deal - TipRanks
Insider Buying: CRISPR Therapeutics AG (NASDAQ:CRSP) Director Buys 989,812 Shares of Stock - MarketBeat
3 Monster Stocks in the Making to Buy Right Now - The Motley Fool
CRISPR Therapeutics (CRSP) Soars 18% After $51-Million Insider Trading - MSN
Q2 EPS Estimate for CRISPR Therapeutics Lifted by Analyst - MarketBeat
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $71.75 Average Price Target from Analysts - MarketBeat
Crispr Therapeutics AG Stock Soars Amid Insider Confidence - TipRanks
CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors - MSN
Is It Worth Investing in CRISPR Therapeutics (CRSP) Based on Wall Street's Bullish Views? - MSN
CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 5.7%What's Next? - MarketBeat
CRSP’s Astounding Gains: Should Investors Jump In? - timothysykes.com
CRISPR Therapeutics (CRSP) Surges after Director Buys over $51M Worth of Shares - TipRanks
Crispr stock soars after director buys $51.5 million in shares - Investing.com
CRISPR Therapeutics Breaks Ground with Promising Phase 1 Trial Advances - timothysykes.com
CRISPR Therapeutics (NASDAQ:CRSP) Hits New 52-Week High Following Insider Buying Activity - MarketBeat
Crispr director George buys $51.5M of shares (CRSP:NASDAQ) - Seeking Alpha
Crispr Therapeutics stock hits 52-week high at 62.32 USD - Investing.com
Director Makes Multi-Million Dollar Investment in Crispr Therapeutics AG! - TipRanks
CRISPR Therapeutics (CRSP) Moves 9.6% Higher: Will This Strength Last? - MSN
Leavell Investment Management Inc. Makes New Investment in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):